在肥胖时代与癌症相关的白内障
Joyce Cristina Ferreira de Resende1, Márcia Fábia Andrade1, Fabiana Amaral Ferreira1
1Cancer Metabolism Research Group, Laboratory of Experimental Surgery (LIM 26), Department of Surgery, Faculdade de Medicina da Universidade de São Paulo, HC-FMUSP, São Paulo 01246-903, Brazil.
International journal of molecular sciences
|December 11, 2025
概括
肥胖和癌症缓解症,虽然是对立的,但共享炎症和代谢变化. 了解这些常见的途径,特别是涉及白色脂肪组织的途径,是开发新疗法的关键.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 炎症研究的研究.
- 脂肪组织生物学 脂肪组织生物学
背景情况:
- 肥胖和癌症缓解症呈现出截然不同的身体质量指数 (BMI) 概况.
- 这两种情况都涉及由炎症和脂肪组织功能障碍驱动的显著代谢变化.
- 慢性炎症和脂肪代谢的改变是常见的潜在因素.
研究的目的:
- 探索肥胖和癌症缓解症的共同炎症和代谢途径.
- 在这些条件下研究白色脂肪组织 (WAT) 的特定作用.
- 突出了解常见机制的治疗潜力.
主要方法:
- 文献综述侧重于炎症和代谢途径.
- 分析白色脂肪组织 (WAT) 在肥胖和癌症缓解症中的作用.
- 综合关于共享机制的当前研究.
主要成果:
- 肥胖和癌症缓解症都表现出炎症性细胞因子 (例如TNF-α,IL-6) 的增加.
- 分享的炎症信号有助于代谢失调和能量失衡.
- 白色脂肪组织 (WAT) 在这两种情况中都起着至关重要的,尽管差异性的作用.
结论:
- 肥胖和癌症缓解症共享基本的炎症和代谢途径.
- 针对这些共同的机制,特别是WAT参与,可能会提供新的治疗途径.
- 对这些共享途径的进一步研究对于有效的管理策略至关重要.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
221
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
Overview of Protein Metabolism
3.5K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.5K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629


